ACRO, Quintiles, PRA and Theorem talk strategic partnering at DIA 2011

By Gareth Macdonald

- Last updated on GMT

Related tags: Contract research organization, Pharmacology

The Big Pharma CRO strategic partnering model, its impact on drug development and the contract research sector was a hot topic at DIA 2011.

Outsourcing-pharma.com asked representatives from Quintiles Transnational, PRA International and Theorem Clinical Research to share their thoughts on such deals and whether they are good for the sector as a whole.

We also spoke with John Lewis, Vice President of Public Affairs at the Association of Clinical Research Organizations (ACRO) who suggested that more research is needed to assess the efficacy of strategic partnerships.

Related news

Show more

Related products

show more

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Parents as Gatekeepers for Children with Cancer

Parents as Gatekeepers for Children with Cancer

PRA Health Sciences | 08-Jun-2020 | Technical / White Paper

The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...

Related suppliers

Follow us

Products

View more

Webinars